OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/05/2026
Back to search
Official data from USPTO
QUTRISI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
08/05/2026
Trademark type
Word
Nice classes
5
Filing date
12/04/2024
Registration date
06/10/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/10/2025
Last transaction
08/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
KEAN, AMY C
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Otsuka Pharmaceutical Co., Ltd.
Representatives
No representative data.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy (IgAN); pharmaceutical preparations for treatment of autoimmune diseases and disorders.
Publications
History of USPTO decisions and trademark events.
15 publications found
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2025
PUBO
PUBLISHED FOR OPPOSITION
04/22/2025
NPUB
NOTICE OF PUBLICATION
04/16/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/24/2025
ATRV
ATTORNEY REVIEW COMPLETED
03/24/2025
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
03/24/2025
DOCK
ASSIGNED TO EXAMINER
03/21/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
03/08/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/29/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/29/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/24/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/23/2025
Continuous trademark protection
Get notified about every new filing that threatens QUTRISI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.